普雷西根生物
PGEN
6.39
-0.81
-11.26%
普雷西根生物
US · PGEN
#2527 按市值排名
上市于 1970
6.39
-0.81
-11.26%
实时 - 追踪5344个代码 - 心跳于21秒前
· 2026-10-16 20:02
最新新闻
-
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $18\u5e02\u573a\u8d44\u8baf · 2026/8/5
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $9\u5e02\u573a\u8d44\u8baf · 2025/11/14
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $10\u5e02\u573a\u8d44\u8baf · 2026/4/2
-
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $18\u5e02\u573a\u8d44\u8baf · 2026/10/1
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $6\u5e02\u573a\u8d44\u8baf · 2025/8/13
-
评级变动
Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $9\u5e02\u573a\u8d44\u8baf · 2026/3/26
-
评级变动
Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $8\u5e02\u573a\u8d44\u8baf · 2025/8/19
-
评级变动
J.P. Morgan Upgrades Precigen(PGEN.US) to Hold Rating\u5e02\u573a\u8d44\u8baf · 2025/8/15
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $8.5\u5e02\u573a\u8d44\u8baf · 2025/8/15
-
H.C. Wainwright Keeps Their Buy Rating on Precigen (PGEN)TipRanks · 2026/10/1
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $10\u5e02\u573a\u8d44\u8baf · 2026/3/26
-
B. Riley Securities Initiates Precigen(PGEN.US) With Buy Rating, Announces Target Price $12\u5e02\u573a\u8d44\u8baf · 2026/9/25
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $14\u5e02\u573a\u8d44\u8baf · 2026/8/3
-
B. Riley Securities Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $12\u5e02\u573a\u8d44\u8baf · 2026/9/25
-
评级变动
Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $6\u5e02\u573a\u8d44\u8baf · 2025/6/13
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $11\u5e02\u573a\u8d44\u8baf · 2026/5/14
-
评级变动
Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $11\u5e02\u573a\u8d44\u8baf · 2026/5/14
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $8.5\u5e02\u573a\u8d44\u8baf · 2025/8/19
-
评级变动
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $14\u5e02\u573a\u8d44\u8baf · 2026/5/28
-
评级变动
Cantor Fitzgerald Maintains Precigen(PGEN.US) With Buy Rating\u5e02\u573a\u8d44\u8baf · 2025/9/26
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 20:02:22 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
普雷西根生物 讨论区 0 条评论